Loading…
Monopar Therapeutics Inc. is projected to rise to $138.27 by 2027, a +28% move from its current price of $108.35. MNPR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $104.43 | $108.44 | $112.61 | +0.09% |
| Aug 3 | $102.91 | $108.54 | $114.48 | +0.17% |
| Aug 4 | $101.77 | $108.63 | $115.96 | +0.26% |
| Aug 5 | $100.84 | $108.73 | $117.23 | +0.35% |
| Aug 6 | $100.03 | $108.82 | $118.38 | +0.43% |
| Aug 7 | $99.31 | $108.91 | $119.44 | +0.52% |
| Aug 8 | $98.67 | $109.01 | $120.43 | +0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $98.67 | $109.01 | $120.43 | +0.61% |
| Week 2 | $95.25 | $109.67 | $126.27 | +1.22% |
| Week 3 | $92.84 | $110.33 | $131.12 | +1.83% |
| Week 4 | $90.94 | $111.00 | $135.49 | +2.45% |
| Week 5 | $89.37 | $111.68 | $139.55 | +3.07% |
| Week 6 | $88.02 | $112.35 | $143.42 | +3.70% |
| Week 7 | $86.84 | $113.04 | $147.14 | +4.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for cancer in the United States.
It develops ALXN1840, MNPR-101, MNPR-101-Zr, and MNPR-101-Lu as part of its pipeline.
The company was founded in 2014 and is headquartered in Wilmette, Illinois.
MNPR trades under the MNPR symbol with a current price of $114.66.
Its market capitalization is $719.65M and it holds the rank 5350 by market cap.
The near-term outlook reflects a mixed but leveling setup, with the 2026 forecast showing an average price of $114.66 (neutral) and later years projecting higher averages, including $297.38 by 2030 and $2,210.66 by 2050.
Overall, the long-run forecast points to a rising trajectory with bullish sentiment in later years.
A major floor 54.2% below — a decisive break under it would weaken the trend.
The nearest floor, 37.7% below — buyers have tended to step in here.
The nearest ceiling, 5.8% above — a clean break opens room to run.
A major ceiling 32.9% above — clearing it would confirm fresh momentum.
Key MNPR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MNPR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $109.97 | Sell | $109.92 | Sell |
| MA 10 | $109.74 | Sell | $108.98 | Sell |
| MA 20 | $106.58 | Buy | $104.39 | Buy |
| MA 50 | $84.68 | Buy | $90.16 | Buy |
| MA 100 | $70.75 | Buy | $78.94 | Buy |
| MA 200 | $71.04 | Buy | $69.60 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.32 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 28.29 | Neutral |
| Williams %R (14) | -42.43 | Info |
| MACD (12,26,9) | -1.24 | Sell |
| ROC (12) | -0.31 | Sell |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 57.57 | Neutral |
| TRIX (15) | 1.42 | Buy |
| Awesome (5,34) | 14.63 | Buy |
| Ultimate (7,14,28) | 49.60 | Neutral |
| Momentum (10) | -2.77 | Sell |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 110.46 | Sell |
| ADX (14) | 37.06 | Buy |
| ATR (14) | 3.61 | Info |
The 30-day technical picture is bullish, with RSI14 at 70.
The near-term momentum is supported by the moving averages, with SMA50 at $83.62 and SMA200 at $71.01.
Support sits at $64.39 and resistance at $114.66, while the 30-day price range spans from $90.02 to $146.04.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $50.12 | $108.35 | $155.86 | 0% | Neutral | |
| $106.47 | $138.27 | $191.99 | +28% | Bullish | |
| $145.90 | $197.34 | $287.84 | +82% | Bullish | |
| $199.76 | $279.50 | $423.43 | +158% | Bullish | |
| $199.09 | $287.09 | $448.87 | +165% | Bullish | |
| $213.86 | $317.05 | $509.44 | +193% | Bullish | |
| $244.40 | $371.87 | $612.25 | +243% | Bullish | |
| $252.58 | $393.89 | $662.87 | +264% | Bullish | |
| $329.18 | $525.57 | $902.40 | +385% | Bullish | |
| $394.06 | $643.61 | $1,125.76 | +494% | Bullish | |
| $573.20 | $1,040.16 | $1,964.84 | +860% | Bullish | |
| $995.14 | $2,187.23 | $4,612.06 | +19.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $50.12 | $108.35 | $141.03 | +0.00% |
| September 2026 | $100.68 | $120.47 | $149.17 | +11.18% |
| October 2026 | $97.06 | $117.23 | $147.27 | -2.68% |
| November 2026 | $96.21 | $117.12 | $148.83 | -0.10% |
| December 2026 | $99.01 | $121.38 | $155.86 | +3.64% |
Click any year to see its month-by-month MNPR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MNPR could reach as high as $155.86, with a base case around $108.35 and support toward $50.12 — roughly 0% from $108.35. Price action looks broadly range-bound.
Expect MNPR to range from $106.47 to $191.99 through 2027. The $138.27 average target implies a +28% move from current prices. That is up +28% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The MNPR price prediction for 2028 points to an average of $197.34 (low $145.90, high $287.84) — a potential gain of +82% on today's $108.35. Momentum favours further upside here.
In 2029, MNPR is projected to trade between $199.76 and $423.43, averaging $279.50 — a potential gain of +158% from today's $108.35. That is up +42% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Monopar Therapeutics Inc.'s 2030 outlook centres on $287.09, within a $199.09 to $448.87 range. That is up +3% on the projected 2029 average. That marks a +165% change versus current levels. Momentum favours further upside here.
By 2031, MNPR could reach as high as $509.44, with a base case around $317.05 and support toward $213.86 — roughly +193% from $108.35. Buyers look set to stay in control over this stretch.
Expect MNPR to range from $244.40 to $612.25 through 2032. The $371.87 average target implies a +243% move from current prices. That is up +17% on the projected 2031 average. Momentum favours further upside here.
The MNPR price prediction for 2033 points to an average of $393.89 (low $252.58, high $662.87) — a potential gain of +264% on today's $108.35. Buyers look set to stay in control over this stretch.
In 2034, MNPR is projected to trade between $329.18 and $902.40, averaging $525.57 — a potential gain of +385% from today's $108.35. That is up +33% on the projected 2033 average. Momentum favours further upside here.
Monopar Therapeutics Inc.'s 2035 outlook centres on $643.61, within a $394.06 to $1,125.76 range. That is up +22% on the projected 2034 average. That marks a +494% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MNPR could reach as high as $1,964.84, with a base case around $1,040.16 and support toward $573.20 — roughly +860% from $108.35. Momentum favours further upside here.
Expect MNPR to range from $995.14 to $4,612.06 through 2050. The $2,187.23 average target implies a +19.2x move from current prices. That is up +110% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MNPR today (≈ 9.229349 MNPR) could be worth
$20,186.75
+$19,186.75 (+1919%) by 2050 · US Dollar
Based on the average projected MNPR price of $2,187.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MNPRwould be worth at today's price.
$1,000 invested in MNPR on Jul 31, 2025 (≈ 24.283633 MNPR) would be worth
$2,631.13
+$1,631.13 (+163.1%) today · 2.63× · US Dollar
Based on a MNPR entry price of $41.18 vs. today's $108.35.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $109.87 | $986.17 | -1.4% |
| 1 month ago | $95.03 | $1,140.17 | +14.0% |
| 3 months ago | $53.25 | $2,034.74 | +103.5% |
| 6 months ago | $65.48 | $1,654.7 | +65.5% |
| 1 year ago | $41.18 | $2,631.13 | +163.1% |
| All time (5.0y) ago | $26.6 | $4,073.31 | +307.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MNPR forecast.
Our base-case forecast reaches $220.00 around 2029.
Implied market cap at $220.00: $1.47B
The multi-year forecast shows bullish sentiment across the horizon, beginning with a neutral stance in 2026 and turning increasingly positive in following years.
In 2027 the avg is $146.98 with a 28.2% ROI, and the pattern continues with strong upside through the late 2020s and into the 2030s.
By 2030, the avg is $297.38 with a 159.4% ROI, reflecting meaningful upside, while 2040 projects an avg of $1,073.69 with an 836.4% ROI and 2050 an avg of $2,210.66 with a 1,828% ROI.
These are estimates rather than guarantees, and the forecast carries uncertainty inherent in long-run projections.
Tap a question to reveal the answer.
The forecast shows an average price of $297.38 in 2030 with a 159.4% ROI; the implied min is $207.56 and max is $461.90.
The year-by-year forecast shifts from neutral in 2026 to bullish in later years, with 2027 avg $146.98 (28.2% ROI) and 2030, 2040, 2050 showing higher averages and stronger ROIs; these are estimates, not guarantees.
The 2050 forecast shows an average of $2,210.66 with a max of $4,607.49 and a 1,828% ROI, suggesting substantial upside in this scenario.
Current price is $114.66 and market cap is $719.65M; the stock is ranked 5350.
RSI14 is 70; SMA50 is $83.62 and SMA200 is $71.01. Support is at $64.39 and resistance at $114.66, with a 30-day range of $90.02 to $146.04.
Monopar Therapeutics Inc. Community Discussion
0Share your Monopar Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.